Cuban scientists advancing research on nasal vaccine against COVID-19
The Xinhua reported according to Eduardo Martinez, president of the state-owned biotechnology and pharmaceutical industries group BioCubaFarma, Cuban scientists are advancing research on a nasal vaccine against COVID-19.
Martinez posted on Twitter: "Final evaluations are underway to complete development of the vaccine, #Mambisa."
The scientist added: "We think it may help prevent transmission of #SARSCoV2 and provide a certain level of immunity."
Martinez assured that the vaccine candidate Mambisa "has demonstrated a high mucosal immune response against SARS-CoV-2 in clinical studies. It could be very effective against transmission."
The Xinhua noted that Cuba has three homegrown vaccines against COVID-19 (Abdala, Soberana-02 and Soberana Plus), which it has used to mass immunize the 11.2 million Cubans.
It said that Mambisa, one of the few nasal application COVID-19 vaccines in the world, and Soberana-01 are two other Cuban vaccine candidates still under research.